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OL-032 Antimicrobial susceptibility of Staphylococcus
aureus isolated from children with impetigo in
China from 2003 to 2007 shows community
associated MRSA to be uncommon and
heterogenous
Lin Ma*,1, Ying Liu1, Fanrong Kong2, Xia Zhang1,
Mitchell Brown2, Yonghong Yang3. 1Department of Dermatology,
Beijing Children’s Hospital, Capital Medical University, Beijing,
China; 2Centre for Infectious Diseases and Microbiology,
Institute of Clinical Pathology and Medical Research (ICPMR),
Westmead, New South Wales, Australia; 3Beijing Pediatric
Research Institute, Beijing Children’s Hospital, Capital Medical
University, Beijing, China
Objectives: To investigate the antimicrobial susceptibility of
Staphylococcus aureus (S. aureus) causing impetigo in children
in China from 2003 to 2007 and further characterized isolates of
community associated methicillin-resistant Staphylococcus au-
reus (CA-MRSA).
Methods: 984 S. aureus isolates were examined for antimicrobial
susceptibility to 11 antimicrobials using agar dilution method.
CA-MRSA isolates were analyzed for Panton Valentine Leuko-
cidin (pvl) genes, and staphylococcal cassette chromosome mec
(SCCmec) typing was performed.
Results: The largest proportion (94.5%) of strains were resistant
to penicillin, followed by erythromycin (86.2%) and clindamycin
(69.6%). In total 772/984 (78.5%) S. aureus were multiresistant.
The incidence of CA-MRSA was 1.1%, which with a high rate of
resistance to clindamycin (90.9%) and tetracycline (72.7%), but
all of them were susceptible to ciproﬂoxacin. The susceptibil-
ity proﬁles of MRSA to other antimicrobial agents were similar
to those of methicillin-sensitive Staphylococcus aureus (MSSA).
None of the S. aureus strains were resistant to vancomycin and
fusidic acid, moreover only one strain was resistant to mupirocin.
Typing of the SCCmec showed that 54.5% were type IV, 18.2%
were type V and 9.1% were type VI. All the pvl- positive CA-MRSA
carried SCCmec IV.
Conclusion: CA-MRSA is still relatively uncommon and heteroge-
nous in children in China. Penicillin and erythromycin are no
longer appropriate agents. Effective antibiotic agents for pa-
tients with impetigo are mupirocin and fusidic acid.
OL-033 Detection of ESBLs and AmpC enzyme produced
by Enterobacter cloacae
Rong Wang*, Xue Li, Shangwei Wu, Ping He, Bumei Zhang,
Yunde Liu. Department of Laboratory Science, Tianjin Medical
University, Tianjin, China
Objective: To establishment and evaluated a new method named
ﬁve-disk agar diffusion method which can test ESBLs and AmpC of
Enterobacter cloacae (E. cloacae) at the same time. The regular
clinical methods, four-disk test which detect the AmpC and the
double-disk synergy test which detect the ESBLs were compared.
Methods: Strains of E. cloacae were isolated and identiﬁed by
automatic microbe system VITEK; ESBLs and AmpC enzyme were
determined by ﬁve-disk agar diffusion method, four-disk test and
double-disk synergy test, respectively.
Results: In 33 strains of E. cloacae, there were 12 (36.4%) strains
produced ESBLs, 3 (9.1%) strains produced AmpC, and 7 (21.2%)
strains produced both ESBLs and AmpC enzymes by ﬁve-disk
test. There were 9 (27.3%) strains produced AmpC enzyme by
four-disk test. Besides, there were 20 (60.6%) strains produced
ESBLs by double-disk synergy test. Compared with four-disk test
and double-disk synergy test, the coincidence rates of ﬁve-disk
synchronous test were 90% and 95% respectively. The positive
rates of ESBLs by ﬁve-disk test and double-disk test have no
signiﬁcance (P>0.05). And the positive rates of AmpC enzyme
by ﬁve-disk test and four-disk test also have no signiﬁcance
(P>0.05).
Conclusion: Five-disk test is simple, rapid and suitable for assay
and differentiation of producing AmpC or ESBLs among E. cloa-
cae. Because allows for testing of AmpC and ESBLs Enzyms on a
single plate, it is also more cost-effective.
OL-034 In vitro activity of daptomycin against
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faecalis isolates at a general hospital
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Background: Daptomycin is a new lipopeptide bactericidal an-
timicrobial agent and introduces a new mechanism of action
against Gram-positive bacteria.
Objectives: To determine the in vitro activitie of daptomycin
against clinical isolates of S. aureus, S. epidermidis, E. faecium
and E. ‘faecalis from inpatients hospitalized in the intensive care
unit of our hospital.
Methods: 235 non-duplicate isolates were chosen for suscep-
tibilty testing in 2008. All patients had the clinical signs and
symptoms of sepsis. This collective comprised 55 isolates of
S. aureus including 28.4% MRSA, 104 of S. epidermidis includ-
ing 42.4% MRSE, 48 isolates of E. faecalis and 27 isolates of
E. faecium. Identiﬁcation and routine antibiograms of the iso-
lates were carried out using the Vitek 2 automated system
(BioMerieux®, Marcy I’Etolie, France). Minimum inhibitory con-
centrations (MICs) of daptomycin was determinated by the agar
dilution method according to Clinical Laboratory Standards Insti-
tute (CLSI) guidelines.
Results: All strains tested of S. aureus and S. epidermidis were
susceptible to daptomycin (MICs ≤ 1 μg/mL) as well as all strains
of E. faecium and E. faecalis (MICs ≤ 4 μg/mL). At established
CLSI breakpoints for vancomycin (4 μg/mL) 100% respectively,
of the all strains isolates was susceptible. At established CLSI
breakpoints for tigecycline (1 μg/mL), 98% of the S. aureus, 99%
of the S. epidermidis and 98% of the E. faecium and E. faecalis
were susceptible. MICs were ranging between 0.03–1 for S. au-
reus, 0.01–1 for S. epidermidis, 0.25–4 for E. faecalis and 0.5–4
for E. faecium, respectively.
Conclusions: The excellent in vitro bactericidal activity of dap-
tomycin presents the potential role of treatment of severe
infections due to these bacteria.
OL-035 A novel sequence-based coa genotyping method
to discriminate nosocomial methicillin resistant
Staphylococcus aureus isolates
Qingtian Li *,1, Yongzhang Zhu1, Ke Dong1, Chang Liu1,
Yuhua Zhou1, Yuxing Ni 2, Xiaokui Guo1. 1Department of Medical
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Background: To evaluate a novel methicillin resistant Staphylo-
coccus aureus genotyping method based on coagulase (coa) gene
sequence.
Methods: Ninety nosocomial MRSA strains isolated from a Chi-
nese university hospital were studied with pvl, SCCmec, spa,
MLST, a novel sequence-based coa typing methods and antibiotic
resistance features.
Results: The prevalent strains were MLST type ST239, ST641 or
